Journal of Preventive Medicine and Public Health

  • 제57권5호
  • /
  • Pages.480-489
  • /
  • 2024
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Excess Deaths in Korea During the COVID-19 Pandemic: 2020-2022

  • So-Jin Im (Department of Health and Medical Policy, Daegu City Hall) ;
  • Ji-Yeon Shin (Department of Preventive Medicine, Kyungpook National University School of Medicine) ;
  • Duk-Hee Lee (Department of Preventive Medicine, Kyungpook National University School of Medicine)
  • 투고 : 2024.05.21
  • 심사 : 2024.07.26
  • 발행 : 2024.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: Excess deaths, an indicator that compares total mortality rates before and during a pandemic, offer a comprehensive view of the pandemic's impact. However, discrepancies may arise from variations in estimating expected deaths. This study aims to compare excess deaths in Korea during the coronavirus disease 2019 pandemic using 3 methods and to analyze patterns using the most appropriate method. Methods: Expected deaths from 2020 to 2022 were estimated using mortality data from 2015-2019 as reference years. This estimation employed 3 approaches: (1) simple average, (2) age-adjusted average, and (3) age-adjusted linear regression. Excess deaths by age, gender, and cause of death were also presented. Results: The number of excess deaths varied depending on the estimation method used, reaching its highest point with the simple average and its lowest with the age-adjusted average. Age-adjusted linear regression, which accounts for both the aging population and declining mortality rates, was considered most appropriate. Using this model, excess deaths were estimated at 0.3% for 2020, 4.0% for 2021, and 20.7% for 2022. Excess deaths surged among individuals in their 20s throughout the pandemic, largely attributed to a rise in self-harm and suicide. Additionally, the results indicated sharp increases in deaths associated with "endocrine, nutritional, and metabolic diseases" and "symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified." Conclusions: Substantial variations in excess deaths were evident based on estimation method, with a notable increase in 2022. The heightened excess deaths among young adults and specific causes underscore key considerations for future pandemic responses.

키워드

참고문헌

  1. Joffe AR. COVID-19: rethinking the lockdown groupthink. Front Public Health 2021;9:625778. https://doi.org/10.3389/fpubh.2021.625778
  2. Ioannidis JP. Over- and under-estimation of COVID-19 deaths. Eur J Epidemiol 202;36(6):581-588. https://doi.org/10.1007/s10654-021-00787-9
  3. Ioannidis JP, Zonta F, Levitt M. Flaws and uncertainties in pandemic global excess death calculations. Eur J Clin Invest 2023; 53(8):e14008. https://doi.org/10.1111/eci.14008
  4. Mathieu E, Ritchie H, Rodes-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus pandemic (COVID-19); 2020 [cited 2023 Feb 1]. Available from: https://ourworldindata.org/coronavirus
  5. Oh JH. Excess deaths during COVID-19, how much more have increased? KOSTAT Stat Plus 2023;Summer:48-60 (Korean).
  6. Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature 2023;613(7942):130-137. https://doi.org/10.1038/s41586-022-05522-2
  7. COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet 2022;399(10334):1513-1536. https://doi.org/10.1016/S0140-6736(21)02796-3
  8. Han C, Jang H, Oh J. Excess mortality during the Coronavirus disease pandemic in Korea. BMC Public Health 2023;23(1):1698. https://doi.org/10.1186/s12889-023-16546-2
  9. Kim JH, Kim S, Park E, Kim CY. Inequitable distribution of excess mortality during the COVID-19 pandemic in Korea, 2020. Epidemiol Health 2022;44:e2022081. https://doi.org/10.4178/epih.e2022081
  10. Shin MS, Sim B, Jang WM, Lee JY. Estimation of excess all-cause mortality during COVID-19 pandemic in Korea. J Korean Med Sci 2021;36(39):e280. https://doi.org/10.3346/jkms.2021.36.e280
  11. Levitt M, Zonta F, Ioannidis JP. Comparison of pandemic excess mortality in 2020-2021 across different empirical calculations. Environ Res 2022;213:113754. https://doi.org/10.1016/j.envres.2022.113754
  12. Barbiellini Amidei C, Fedeli U, Gennaro N, Cestari L, Schievano E, Zorzi M, et al. Estimating overall and cause-specific excess mortality during the COVID-19 pandemic: methodological approaches compared. Int J Environ Res Public Health 2023;20(11):5941. https://doi.org/10.3390/ijerph20115941
  13. Microdata Integrated Service. Causes of death statistics [cited 2023 Feb 1]. Available from: Available from: https://mdis.kostat.go.kr/dwnlSvc/ofrSurvSearch.do?curMenuNo=UI_POR_P9240 (Korean).
  14. Aron J, Muellbauer J, Giattino C, Ritchie H. A pandemic primer on excess mortality statistics and their comparability across countries; 2020 [cited 2023 Feb 1]. Available from: https://ourworldindata.org/covid-excess-mortality
  15. Lim S, Sohn M. How to cope with emerging viral diseases: lessons from South Korea's strategy for COVID-19, and collateral damage to cardiometabolic health. Lancet Reg Health West Pac 2023;30:100581. https://doi.org/10.1016/j.lanwpc.2022.100581
  16. Bhattacharya J, Magness P, Kulldorff M. Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes. Adv Biol Regul 2022;86:100916. https://doi.org/10.1016/j.jbior.2022.100916
  17. Sawano T, Kotera Y, Ozaki A, Murayama A, Tanimoto T, Sah R, et al. Underestimation of COVID-19 cases in Japan: an analysis of RT-PCR testing for COVID-19 among 47 prefectures in Japan. QJM 2020;113(8):551-555. https://doi.org/10.1093/qjmed/hcaa209
  18. Park Y, Huh IS, Lee J, Kang CR, Cho SI, Ham HJ, et al. Application of testing-tracing-treatment strategy in response to the COVID-19 outbreak in Seoul, Korea. J Korean Med Sci 2020;35(45):e396. https://doi.org/10.3346/jkms.2020.35.e396
  19. Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A, et al. Asymptomatic SARS-CoV-2 infection by age: a global systematic review and meta-analysis. Pediatr Infect Dis J 2023;42(3):232-239. https://doi.org/10.1097/INF.0000000000003791
  20. Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, et al. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep 2021;11(1):8380. https://doi.org/10.1038/s41598-021-87688-9
  21. Tanaka H, Togawa K, Katanoda K. Impact of the COVID-19 pandemic on mortality trends in Japan: a reversal in 2021? A descriptive analysis of national mortality data, 1995-2021. BMJ Open 2023;13(8):e071785. https://doi.org/10.1136/bmjopen2023-071785
  22. Doshi P. Covid-19: do many people have pre-existing immunity? BMJ 2020;370:m3563. https://doi.org/10.1136/bmj.m3563
  23. Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E, et al. The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. Nat Rev Immunol 2023;23(5):304-316. https://doi.org/10.1038/s41577-022-00809-x
  24. Souilmi Y, Lauterbur ME, Tobler R, Huber CD, Johar AS, Moradi SV, et al. An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. Curr Biol 2021;31(16):3504-3514. https://doi.org/10.1016/j.cub.2021.05.067
  25. Sanchez CA, Li H, Phelps KL, Zambrana-Torrelio C, Wang LF, Zhou P, et al. A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia. Nat Commun 2022;13(1):4380. https://doi.org/10.1038/s41467-022-31860-w
  26. Nguyen TT, Choo EM, Nakamura Y, Suzuki R, Shiina T, Shin-I T, et al. Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam. Int J Infect Dis 2024;139:109-117. https://doi.org/10.1016/j.ijid.2023.11.008
  27. Pezzullo AM, Axfors C, Contopoulos-Ioannidis DG, Apostolatos A, Ioannidis JP. Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environ Res 2023;216(Pt 3):114655. https://doi.org/10.1016/j.envres.2022.114655
  28. Ryu S, Nam HJ, Jhon M, Lee JY, Kim JM, Kim SW. Trends in suicide deaths before and after the COVID-19 outbreak in Korea. PLoS One 2022;17(9):e0273637. https://doi.org/10.1371/journal.pone.0273637
  29. Kim S, Sung HK, Kim T, Ko SK, Kim S, Lee JH. Trends in emergency department visits for suicide attempts before and during the COVID-19 pandemic in Korea: a nationwide study, 2016-2021. J Affect Disord 2023;331:184-191. https://doi.org/10.1016/j.jad.2023.03.037
  30. Sakamoto H, Ishikane M, Ghaznavi C, Ueda P. Assessment of suicide in Japan during the COVID-19 pandemic vs previous years. JAMA Netw Open 2021;4(2):e2037378. https://doi.org/10.1001/jamanetworkopen.2020.37378
  31. Bridge JA, Ruch DA, Sheftall AH, Hahm HC, O'Keefe VM, Fontanella CA, et al. Youth suicide during the first year of the COVID-19 pandemic. Pediatrics 2023;151(3):e2022058375. https://doi.org/10.1542/peds.2022-058375
  32. Sayed AA, El-Gendy AA, Aljohani AK, Haddad RA, Taher OH, Senan AM, et al. The effects of COVID-19 on the mental health of children and adolescents: a review. Cureus 2024;16(3):e56473. https://doi.org/10.7759/cureus.56473
  33. Woo HG, Park S, Yon H, Lee SW, Koyanagi A, Jacob L, et al. National trends in sadness, suicidality, and COVID-19 pandemic-related risk factors among South Korean adolescents from 2005 to 2021. JAMA Netw Open 2023;6(5):e2314838. https://doi.org/10.1001/jamanetworkopen.2023.14838
  34. Giuntella O, Hyde K, Saccardo S, Sadoff S. Lifestyle and mental health disruptions during COVID-19. Proc Natl Acad Sci U S A 2021;118(9):e2016632118. https://doi.org/10.1073/pnas.2016632118
  35. Nomura S, Nishio M, Abe SK, Eguchi A, Inoue M, Suzuki M, et al. Impact of the COVID-19 pandemic on cancer death locations in Japan: an analysis of excess mortality through February 2023. J Epidemiol 2024;34(7):349-355. https://doi.org/10.2188/jea.JE20230235
  36. Scholey J, Karlinsky A, Kobak D, Tallack C. Conflicting COVID-19 excess mortality estimates. Lancet 2023;401(10375):431-432. https://doi.org/10.1016/S0140-6736(23)00116-2